About Us Practices Professionals Results News & Events Publications Careers Contact Us PTAB Blog Biosimilars Blog Privacy Blog RF EMerge Blog Publications Precise. Insightful. Skilled. Search Publications Publications Rothwell Figg’s Christopher Ott Updates Article in ICLG Cybersecurity 2022 on Data Security and Privacy Lapses Leading to Personal Liability Partner Christopher Ott updated the article he previously wrote titled “Phantom Responsibility: How Data Security and Privacy Lapses Lead to Personal Liability for Officers and Directors" for the International Comparative Legal Guide to: Cybersecurity 2022,… More Steven Lieberman and Jennifer Nock Contribute to The Sedona Conference WG10 Commentary on Patent Litigation Best Practices: Unique Aspects of Biopharma Litigation Chapter Rothwell Figg partners Steve Lieberman and Jennifer Nock, who are members of The Sedona Conference Working Group 10 on Patent Litigation Best Practices (WG10), played a leading role in authoring and bringing to publication for… More The mRNA IP and Competitive Landscape, A Three Part Series Partner Daniel Shores, associate Dylan Haversack, and patent agent Andrew Storaska, Ph.D. authored a three-part series titled "The mRNA IP and Competitive Landscape" for IPWatchdog.com, the largest online intellectual property publication in the world and a… More The Licensing Journal Republishes PTAB Law Blog Article by Richard Waterman Associate Richard Waterman's article "Kannuu v. Samsung: Forum Selection Clause Did Not Prohibit IPR Challenges" was recently republished in volume 41, number 3 of The Licensing Journal, a publication by Wolters Kluwer. Originally published on Rothwell… More NSCAI Final Report: United States Must Up Its IP Game to Win the AI Race Partner Jennifer B. Maisel authored an article titled "NSCAI Final Report: United States Must Up Its IP Game to Win the AI Race" for IPWatchdog.com, the largest online intellectual property publication in the world and a leading… More View All Publications RF EMerge Blog Rothwell Figg’s Emerging Companies Blog, RF EMerge, is a resource for early-stage companies providing content on common challenges they face, pertinent industry trends and analysis, and key legal developments affecting emerging companies. The content on the site is generated and edited by Rothwell Figg attorneys who serve such growth companies in our Emerging Companies practice team. To learn more, please visit www.RFEMerge.com. Visit Blog Privacy Blog Rothwell Figg’s blog, Privacy Zone, offers insights on developments in privacy, data protection, and cybersecurity laws, regulations, cases, and news in the U.S. and internationally. The blog is authored by attorneys in the firm’s Privacy, Data Protection, and Cybersecurity practice group, all of whom are technology-focused advisors and litigators as well as Certified Information Privacy Professionals in the United States (CIPP/US). Combined with technical backgrounds and industry experience in computer science, artificial intelligence/machine learning, Internet of Things (IoT), cryptocurrency, blockchain, fintech, bioinformatics, connected device technology, wearables, big data, and adtech, we are uniquely qualified to assess and address the issues at the forefront of these evolving areas of law. To learn more, please visit www.theprivacylaw.com. Visit Blog Biosimilars Blog BiosimilarsIP.com features articles, updates, and analysis on regulatory issues, legal decisions, and other news related to biologics and biosimilars under the Biologics Price Competition and Innovation Act (BPCIA). The posts, authored and edited by attorneys in the firm’s Biologics and Biosimilars practice group, track regulatory issues and events, provide analysis of legal decisions from federal courts and from the Patent Trial and Appeal Board, and offer updates on current news and events related to biologics and biosimilars. Our team understands the manufacturing, regulatory, and legal requirements of the field, and has the experience and the technical knowledge to handle the most sophisticated matters, including issues related to regulatory approval, securing patent rights, counseling and opinions, post-grant challenges, and asserting or defending against patents in litigation. To learn more, please visit www.BiosimilarsIP.com. Visit Blog PTAB Blog Authored and edited by attorneys in the firm’s Post-Grant Trial practice group, PTABLaw.com provides updates, articles, and analysis about the Patent Trial and Appeal Board (PTAB), the Court of Appeals for the Federal Circuit, and the America Invents Act. Our group has considerable experience handling inter partes review (IPR), covered business method (CBM) review, and post-grant review (PGR) proceedings before the PTAB. Our depth of knowledge and expertise with handling matters before the PTAB is unique, as many of the attorneys in our group have substantial experience in handling interference proceedings and reexaminations, and in prosecuting applications before the Office, as well as extensive litigation experience in the federal courts. To learn more, please visit www.PTABLaw.com. Visit Blog © 2021 Rothwell, Figg, Ernst & Manbeck, P.C. All Rights Reserved Disclaimer Privacy Policy Site Map X We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. AGREE For more information, please see our Privacy Policy.